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Neurotransmitter sodium symporters (NSSs) are important for the regulation of neurotransmitters, such as dopamine and
serotonin, which are involved in addiction and depression, along with several other diseases. The bacterial NSS, LeuT,
has been proven to be a good model protein for the mammalian NSSs. Conformational changes of LeuT can be examined
using transition metal ion Förster Energy Resonance Transfer (tmFRET), where the energy transfer between a fluorescien
dye and a di-histidine bound Ni2+ is measured. When utilizing tmFRET, free Ni2+ is added to the solution, which also
adds to the unspecific quenching signal detected. It is therefore necessary to remove the signal from the unbound Ni2+,
in order to properly investigate the impact of specific bound Ni2+. Here we investigate whether the effect of Zn2+ can be
used to inhibit FRET contribution from specifically bound Ni2+ and thereby isolate the non-specific signal. We found that
Zn2+ can competitively inhibit the binding of Ni2+ to the di-histidine motif of LeuT, thereby representing an easier, and
perhaps more consistent, method for removing the signal from unbound Ni2+ during tmFRET measurements.
1 Introduction
Transport proteins are essential building blocks of life.
They are among other things involved in transporting
ions and small molecules, such as neurotransmitters or
amino acids across biological membranes. The major-
ity of known neurotransmitter transporters belong to the
neurotransmitter sodium symporter (NSS) family1. NSSs
transport their solute by utilizing the energy gained from
the sodium gradient, which is created by the Na+/K+ AT-
Pase. Furthermore, all mammalian NSS co-transport Cl-.1
Important members of this family include transporters
of dopamine (DAT), noradrenaline (NET) and serotonin
(SERT).2 NSSs are involved in the removal of transmit-
ters from the synapse, thereby terminating transmission
from neurotransmitters. This involvement in the control of
synaptic signaling has made NSSs key targets for therapeu-
tics and illicit drugs, such as cocaine or amphetamines3.
The regulation of neurotransmitters such as dopamine and
serotonin are thereby involved in addiction, as well as de-
pression and other diseases such as ADHD or schizophre-
nia4. This makes NSSs very interesting to examine. How-
ever, the mammalian transporters have proven exception-
ally challenging to purify sufficiently, as satisfactory sta-
bility, yield and purity has been difficult to obtain in order
to properly investigate their structure. The bacterial NSS,
LeuT, from the Aquifex aeolicus has, however, proven to
be much easier to purify. Furthermore, LeuT has been
shown to be a suitable model protein, as a high degree of
structural conservation has been observed between LeuT
and the mammalian NSSs5. Crystal structures of the mam-
malian SERT and dDAT, show great similarity to the LeuT
structure6 7. Like most NSSs LeuT has 12 transmembrane
domains, as well as a substrate binding site adjacent to
two Na+-binding sites located roughly halfway though the
membrane bilayer.8 LeuT is an amino acid transporter.
LeuT undergoes structural conformations in order to trans-
port its solute. Recent studies, based on tmFRET exper-
iments, suggest that LeuT has an outward-open confor-
mation when Na+ is bound, but adapts an outward-closed
conformation in the presence of K+, when examining the
extracellular side.2 9
Förster Resonance Energy Transfer (FRET) is useful
for investigating molecular distances. Conventional FRET
utilizes the energy transfered from a donor fluorophore,
which has been excited by energy from a light source, to
an acceptor fluorophore (Figure S1). The FRET efficiency,
E, decreases inversely to the sixth power of the distance, R,
between the donor and acceptor fluorophore. This is given
by the equation E = R60/(R
6
0 +R
6), where R0 is the crit-
ical transfer distance, also known as the Förster distance,
and represents the donor-acceptor distance where the ef-
ficiency of the energy transfer is 50 %.10 While FRET is
very useful for intermolecular investigations, it is not al-
ways suitable for the investigations of intramolecular con-
formational movements, due to the limited window around
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Fig. 1 Cartoon of LeuT with EL4:TM10 tmFRET pair shown in
outward open and outward closed states depicting the principle
behind changes in tmFRET as a result of conformational
changes. The tmFRET pair reports distance-dependent
quenching of fluorescence from fluorescien conjugated to an
inserted cysteine at the top of TM10 (orange sphere, K398C) by
Ni2+ coordinated by a His-X3-His motif in EL4 (green sphere,
A313H-A317H). Figure adapted from Billesbolle et al [2016]2
R0. This is primarily due to the high R0 values of typical
FRET pairs (30-60 Å), as well as the large size of most
fluorescent dyes and the dependence upon the orientation
of the fluorophores, which all can influence the FRET ef-
ficiency.11
Transition metal ion FRET (tmFRET), however, has
proven to be very useful for investigating intramolecular
conformational movements of proteins12 (Supporting in-
formation S1. Theory). Using tmFRET, R0 values are re-
duced to about 10 Å.13 Using tmFRET it is possible to
measure the FRET between fluorescien, bound to an in-
serted cysteine, and a Ni2+ ion, which have a R0 of about
12 Å.13 The Ni2+ ion is bound by a di-histidine motif,
which has been introduced into the protein by adding two
histidines, spaced one turn apart in an alpha helix14. The
fluorescien binds to the the cystein by its malamide group,
which reacts with the cystein’s thiol group. The ability to
bind fluorophores to inserted cysteins, is another reason to
use LeuT for investigating NSSs. LeuT doesn’t naturally
have any cysteins, in contrast to many mammalian NSSs,
which allows us to insert a cystein strategically, enabling
us to utilize it for tmFRET.
To investigate tmFRET in LeuT, we inserted a cystein in
K398 at the top of TM10 and a di-histidine site in the heli-
cal part of EL4 (Figure 1). The construct K398C-A313H-
A317H will from here on be named LeuTtmFRET. In order
to measure specific binding for FRET it is necessary to
remove the signal from the unbound Ni2+ ions in the solu-
tion. This problem has previously been addressed by also
conducting the same measurements on a protein without
the di-histidine motif, LeuT mutant K398C (LeuTK398C).
Thus being able to remove the contribution from the un-
bound Ni2+ by subtracting the LeuTK398C signal from the
LeuTtmFRET signal. One study showed that it is possible
to entirely remove the effect of Ni2+ by adding Zn2+ to the
solution.2 As Zn2+ is colorless, it should not be able to ab-
sorb energy from the relaxation of fluorescien to its ground
state. At high enough concentrations the Zn2+ ions will
competitively inhibit the binding of Ni2+ at the di-histidine
motif. This should make it possible to use the Zn2+ satu-
rated LeuTtmFRET mutant to remove the signal from the un-
bound nickel, rather than using LeuTK398C. In this way it
would be possible to completely forgo the LeuTK398C mu-
tant, thereby optimizing the process. The purpose of this
paper is to investigate the effect of Zn2+ ions binding to
the di-histidine motif, aiming to find an alternative to the
LeuTK398C mutant for removal of the contribution from the
unbound Ni2+.
2 Results and Discussion
2.1 Purification of LeuT
The LeuT mutants were purified twice on two separate oc-
casions. The protein concentration was first examined by
absorption at 280 nm. Fractions of 1 mL from the protein
elution were examined, and the fractions with the high-
est protein concentrations were then mixed and aliqouted.
The total average protein concentrations for each purifica-
tion are summarized in table 1. (Further information in
Figures S4 and S5)
Table 1 Total protein concentrations from purifications
1st purification 2nd purification
LeuT(K398C) 0,429 mg/L culture 0,577 mg/L culture
LeuT(tmFRET) 0,105 mg/L culture 0,0496 mg/L culture
The degree of labeling was calcuated to be 64.7 %
for LeuTK398C and 74.19% for LeuTtmFRET (Experimental
section 3.2) for the first purification.
Protein purity was determined using SDS PAGE (Fig-
ure 2). Fraction 1 shows the wash after LeuT was bound
the Ni2+ resin, where other membrane proteins not bound
to the resin can be observed. Fractions A-H show protein
elution. Here, the gel shows a clear band at 37 kD, how-
ever, we know that LeuT has a molecular weight of about
58 kD15. This difference could be due to the common ob-
servation of ”gel-shifting”, when working with membrane
proteins. Gel-shifting is a result of the larger amount of
hydrophobic domains binding more SDS, therefore mak-
ing the protein run faster on the gel.16 A small band at 75
kD can also be observed for LeuTK398C. This could per-
haps indicate the presence of a LeuT dimer.
Scintillation proximity assay (SPA) was performed in
order to investigate amino acid binding of the LeuT mu-
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Fig. 2 Determination of LeuT molecular weight using
SDS-PAGE from second LeuT purification. Fraction 1 shows
the wash after LeuT was bound to the Ni2+ resin, fractions 2-5
are from the wash with increasing amounts of imidazole diluted
in NSWB (0, 60, 90, 100 mM, respectively), fractions A-H show
protein elution with 300 mM imidazole. M indicates the
kaleidoscope marker Left) LeuTK398C right) LeuTtmFRET
tants compared to wild type LeuT LeuTWT (Supporting
information S2. Methods). The histidine tail binds to
the YSi-Cu2+ HisTag beads. The scintillation liquid in the
YSi-Cu2+ HisTag beads will then emit photons, when ex-
posed to β -radiation. Radiotracer 3H-leucine was used.
The competitive binding between 3H-leucine and amino
acids, leucine and alanine, was investigated (Figure 3a and
3b). It was observed that both LeuTK398C and LeuTtmFRET
had leucine and alanine binding affinity comparable to
LeuTWT. Comparing the two, it appears that the binding
affinity for leucine is better than for alanine, despite the
fact that some studies show that alanine is actually trans-
ported more easily by LeuT. This could be due to leucine’s
binding affinity, being so high that it actually could slow
transport15.
From the SPA data it was possible to determine Half
maximal effective concentration EC50 (Table 2). The
EC50 values for the LeuT mutants correlate well with
LeuTWT.
Table 2 EC50 values for LeuT mutants
EC50 LeuTWT LeuTK398C LeuTtmFRET
Ala 8.5 µM 15 µM 14 µM
Leu 28 nM 0.1 nM 33 nM
The leucine saturation of the mutants does not diverge
much from LeuTWT either (Figure 3c). Kd was determined
from the saturation of leucine to be 13 +/- 3 for LeuTWT,
7.6 +/- 1.7 for LeuTK398C and for LeuTtmFRET it was deter-
mined to 10 +/- 2. Thus, confirming that the mutation of
the protein does not appear to have an influence on its affin-
ity for leucine. The sodium dependency on leucine binding
was also investigated (Figure 3d). It can be observed that
this dependency has been retained in the LeuTK398C and
LeuTtmFRET mutants, compared to LeuTWT.
Fig. 3 SPA data shows, LeuT mutants show same saturation and
affinity for leucine as wild type LeuT a) LeuTK398C and
LeuTtmFRET affinity for leucine correlates with LeuTWT b)
LeuTK398C and LeuTtmFRET affinity for alanine correlates with
LeuTWT c) Leucine saturation d) Leucine sodium dependency.
n=1, performed in duplicates
2.2 tmFRET investigation of LeuT
tmFRET was conducted on LeuTK398C and LeuTtmFRET in
20 mM Tris-HCl pH 8.0, 200 mM ChCl, 100 uM TCEP
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and 0.05 % DDM buffer. At increasing concentrations of
Ni2+, a saturation of tmFRET signal can be observed (Fig-
ure 4). At 10 mM Ni2+ there will almost constantly be
a Ni2+ ion coordinated to the di-histidine site, which will
give off the maximum possible tmFRET signal for the pro-
tein.
Fig. 4 tmFRET measurements of LeuT a) Fluorescent
quenching of LeuTK398C and LeuTtmFRET b) tmFRET of LeuT,
where signal from unspecific Ni2+ has been removed by
subtraction of LeuTK398C signal. n=1, performed in triplicates
2.3 Screening for optimal Zn2+ conditions
The buffer used previously for tmFRET on LeuT was a
20 mM Tris-HCl pH 8.0, 200 mM ChCl, 100 uM TCEP
and 0.05 % DDM buffer.2 However, this buffer quickly
proved to be unsuitable for solubilizing Zn2+ as it precipi-
tated (Figure 5). It was therefor necessary to find a differ-
ent buffer both suitable for the protein and for solubilizing
the Zn2+. As the histidine side chain of LeuT has a pKa of
6.04, the buffer was constricted to pH above about 6.5 in
order to keep the histidines from protonating.
In order to determine which component of the buffer
was causing the precipitate, 10 mM ZnCl2 was added to
four solutions, each missing one component of the original
buffer. Each solution was incubated at room temperature
for 10 minutes and precipitate investigated. It was found
Fig. 5 Zn2+ precipitate, 10 mM ZnCl2 in Tris-based
fluorescence buffer at pH 8.0
that only the solution without Tris-HCl did not form pre-
cipitate. Indeed, it has previously been shown that Zn2+
forms complexes with Tris17. Other buffer components
were investigated to replace Tris. However, the solubil-
ity of Zn2+ is also highly dependent on pH, therefore the
Tris based buffer was also tested at pH 7.5. For all buffers
tested, ZnCl2 was added and centrifuged. Surprisingly,
the Tris buffer showed no pellets at 10 mM ZnCl2. How-
ever, when this buffer was used for tmFRET on the pro-
tein with Zn2+, it showed higher FRET signal than other
buffers tested (Figure 6c compared to 6a). This indicates
that Tris may still be forming invisible complexes with the
Zn2+ ions, which might prevent Zn2+ from binding to the
di-histidine motif.
Several other buffers were tested. All buffers were cen-
trifuged with varying concentrations of ZnCl2 for 5 min at
1000 g in order to view pellets from Zn2+. Previous stud-
ies suggested buffers from the morpholinic or piperazinic
families for the best suitability with Zn2+ ions.18 The re-
sults of buffer tests executed are summarized in Table 3.
Coincidentally, some of these buffers had buffer ranges at
slightly lower pH than the Tris family. It was found that
pH was a determining factor in preventing Zn2+ precipita-
tion. Additionally, it was found that Tris is an unsuitable
buffer component when using Zn2+, as it appears that Zn2+
isn’t capable of competitively inhibiting Ni2+ in the Tris
buffer as well as in other buffers, such as MOPS (Figure
6). This is most likely due to complexes formed between
Zn2+ and Tris. Comparing experiments conducted in the
MOPS pH 7.0 and MOPS pH 7.5 buffer, the MOPS pH
7.0 buffer showed slightly lower FRET signals in the pres-
ence of Zn2+ (Figure 6). This indicates that the MOPS 7.5
buffer could have been continuing to interact with the Zn2+
ions, in a manner which disturbed the FRET signal. There-
fore, all further experiments were conducted with MOPS
pH 7.0 buffer.
Additionally, it was attempted to stabilize Zn2+ through
the addition of other substrates. Citric acid and ammonium
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Fig. 6 tmFRET results from LeuT in different buffers at varying
Zn2+ concentrations with 10 mM Ni2+ a) MOPS buffer pH 7.0
b) MOPS buffer pH 7.5 c) Tris buffer pH 7.5, show higher
signals in Tris buffer and MOPS pH 7.5 buffer compared to
MOPS pH 7.0 buffer. n=1, performed in triplicates
chloride were tested, as these have been found to form
complexes with Zn2+ 19, which might stabilize the Zn2+,
but still allow it to bind the the di-histidine motif. 10 mM
of the substrates were added to the chosen buffer and cen-
trifuged with 10 mM Zn2+, in order to view Zn2+ pellets.
When citric acid was added and the pH was adjusted to
8.0 using KOH, there was no significant difference in pel-
let size. There was no difference in pellet size observed at
the addition of ammonium chloride either, indicating that
neither citric acid or ammonium chloride was capable of
keeping Zn2+ from precipitating.
Table 3 Summary of Zn2+ precipitation in different buffers at
varying pH
10 mM Zn2+ 2.5 mM Zn2+
Hepes pH 8.0 Pellet
EPPS pH 8.0 Pellet
MOPSO pH 7.5 Small pellet No pellet
MOPS pH 7.5 Small pellet No pellet
MOPS pH 7.0 Small pellet No pellet
MOBS pH 8.0 Pellet Pellet
Tris pH 8.0 Pellet Pellet
Tris pH 7.5 No pellet No pellet
2.4 The impact of Zn2+ on FRET signal
In order to confirm that the protein still behaved as pre-
viously in the MOPS buffer, FRET values for the protein
were measured in buffers with different salts; ChCl, NaCl
and KCl (Figure 7). In general, the tmFRET values were
consistent with values observed in the lab on previous oc-
casions (unpublished).
Fig. 7 Effect of different salts on tmFRET signal at 10 mM
Ni2+. From the left: ChCl, NaCl and KCl. Slightly heightened
tmFRET signal at KCl indicate effect of K+ on protein
conformation. n=1, performed in triplicates
In the KCl buffer we observe a slightly higher FRET
value than for the ChCl and NaCl (Figure 7). This could
indicate the K+-effect of conformational change from out-
ward open to inward open conformation, as described in
previous studies.2
The effect of addition of Zn2+ was investigated (Figure
8a). Here it is shown that Zn2+ inhibition of Ni2+ binding
is concentration dependent. At increasing concentrations
of Zn2+ the saturation point is likewise pushed towards the
right, as the Ni2+ and Zn2+ compete for the di-histidine
binding site, also indicating the competitive binding. At 5
mM Zn2+ an almost complete inhibition of Ni2+ binding
was observed. Observing this, it can be deduced that it
is possible to use the signal from LeuTtmFRET with 5 mM
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Fig. 8 tmFRET saturation curves at different Zn2+
concentrations a) using LeuTK398C to remove contribution from
the unbound Ni2+ b) using LeuTtmFRET with 5 mM Zn2+ to
remove contribution from the unbound Ni2+. Data indicates 5
mM of Zn2+ can almost completely out-compete Ni2+ at the
di-histidine motif. n=2, in triplicates
ZnCl2 to remove the contribution from the unbound Ni2+
(Figure 8b). This finding should make subtraction of the
contribution from LeuTK398C mutant unnecessary, hereby
making purification faster and easier, as well as possibly
making measurements more consistent as they would be
made on the same LeuT mutant.
The concentration dependent inhibition of Ni2+ bind-
ing to the di-histidine motif can be illustrated as on Fig-
ure 9. Here it can be observed how the Zn2+ ions in-
crease the fluorescent quenching, by competitively inhibit-
ing Ni2+ binding at the di-histidine motif. At 5 mM an al-
most complete blocking of the signal from the Ni2+ bound
to the di-histidine motif is observed, hereby rendering the
LeuTK398C and LeuTtmFRET essentially identical (Figure
9d).
The effect of Zn2+ ions on the intensity was investigted.
Despite the fluorescence quenching signals of LeuTK398C
Fig. 9 Fluorescent quenching at increasing concentrations of
Zn2+ a) 0 mM Zn2+ b) 100 uM Zn2+ c) 1 mM Zn2+ d) 5 mM
Zn2+ shows increasing quenching of the LeuTtmFRET mutant.
n=2, in triplicates
and LeuTtmFRET appearing identical (Figure 9), an effect
of Zn2+ on the protein was observed (Figure 10). The in-
tensity was measured on the LeuTK398C mutant with in-
creasing concentrations of Zn2+ (Figure 10a). Here, the
presence of Zn2+ surprisingly increases the intensity. This
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Fig. 10 Zn2+ titration curves a) LeuTK398C shows increasing intensity at increasing concentrations of Zn2+, when incubated for one
hour before measurements b) LeuTK398C shows no difference in intensity at increasing concentrations of Zn2+, when measured
immediately after addition of Zn2+ c) Both LeuTK398C and LeuTtmFRET with 10 mM Ni2+ show increasing intensity at increasing
concentrations of Zn2+ d) Zn2+ titration curve with fluorescien, but without protein shows no significant difference at increasing
concentrations of Zn2+. a and c n=2, in triplicates. b and d n=1, in triplicates
increase in intensity is not observed if measured immedi-
ately after addition of Zn2+ (Figure 10b), indicating that
the sample may need time to potentially form complexes
or react with LeuT.
The titration of Zn2+ in both the LeuTK398C and
LeuTtmFRET mutant in the presence of 10 mM Ni2+ was
investigated (Figure 10c). Here we also see an increase of
intensity in both the LeuTK398C and LeuTtmFRET mutant in
the presence of Zn2+. In order to investigate if this property
was a function of Zn2+ and the protein itself or of Zn2+ and
the fluorescien directly, Zn2+ was titrated into buffer con-
taining free fluorescien, not coupled to LeuT (Figure 10d).
This indicates that the Zn2+ concentration does not have
an influence on the signal, when the protein is not present.
This indicates that the increased intensity must be due to
an effect Zn2+ has on LeuT, which in turn, influences the
fluorescien intensity.
If this increase in intensity from Zn2+ comes from com-
plexes or an effect on the protein, it poses a problem in
using a Zn2+ inhibited LeuTtmFRET to subtract the signal
from the unbound Ni2+, as it won’t be completely accu-
rate at high concentrations. No great difference in inten-
sity as a function of Zn2+ concentration is observed on the
LeuTK398C signal till about 2 mM (Figure 10c). This could
allow the usage of Zn2+ inhibited LeuTtmFRET to subtract
the signal from the unbound Ni2+, only using a lower con-
centration of Zn2+. It appears that a concentration of 1 mM
Zn2+, does not change the intensity and thus could be used
(Figure 10c). This would not allow as high a concentration
of Ni2+, as the lower Zn2+ concentration would not be able
to competitively inhibit it, thus removing the signal. It can
be deduced that a concentration of 1 mM Ni2+, should be
able to be competitively inhibited by 1 mM Zn2+ (Figure
8a). While not being able to do a full saturation curve with
only 1 mM Ni2+, it still allows for a relatively good indica-
tion of comparative FRET and conformation of the LeuT
protein. Even with these limitations, this method has the
advantage of being able to do measurements on the same
protein.
This allows measurements to be more consistent, as they
will no longer be a comparison between two different mu-
tants of LeuT. This will make it possible to forgo the pu-
rification of LeuTK398C, thereby optimizing the purifica-
tion process. However, this increased intensity could also
be due to the inner filter effect. The inner filter effect has
previously been observed in the lab from Ni2+. If this is
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the case, using Zn2+ inhibited LeuTtmFRET may actually
offer a better solution, as it would not only only allow us
to conduct the measurements on the same protein, but it
would also allow for the subtraction of the inner filter ef-
fect. To determine if these findings are significant, fur-
ther experiments would have to be conducted and statisti-
cal tests would have to be done.
3 Experimental section
3.1 Purification of LeuT
Unless otherwise stated, all chemicals used were pur-
chased from Sigma-Aldrich. Two mutants of LeuT
were purified; A313H-A317H-K398C (LeuTtmFRET) and
K398C (LeuTK398C) - one with and without the di-
histidine motif.
For the purification the following buffers were used:
Lysis buffer (LYB), Sucrose buffer (SUB), Solubilization
buffer (SOB) and No Sodium Wash Buffer (NSWB).
Lysis buffer: 100 mM KCl, 50 mM Tris-Hcl (pH 8.0)
Sucrose buffer: 100 mM KCl, 50 mM Tris-HCl (pH
8.0), 1mM EDTA, 0.5 M sucrose
Solubilization buffer: 50 mM Tris-HCl (pH 8.0), 30 %
glycerol, 300 mM KCl, 5 mM MgCl2, 1 mM TCEP
No Sodium Wash Buffer: 20 mM Tris-HCl (pH 7.5),
200 mM KCl, 100 uM TCEP, 20 % glycerol, 0.05 % n-
dodecyl-β -D-maltosepyranoside (DDM) (Anatrace)
One aliquot freestock of the E. Coli Stock strain C41,
transformed with the desired LeuT construct was added to
Lysogeny Broth containing 75 ug/ml ampicilin and grown
overnight at 37C with 180 rpm shaking.
50 ml inoculation culture was added to 1000 mL LB
containing ug/ml ampicilin and grown for 2.5 hours at
37C. Protein expression was induced at OD600 0.5-0.6
by the addition of isopropyl β -D-1-thiogalactopyranoside
(IPTG). The culture was then incubated at 20C with 180
rpm shaking overnight.
The cells were pelletzied for 10 min at 6000 rpm 4
C in Sorvall LYNX 6000 Superspeed centrifuge (Thermo
Fisher Scientic Inc.). The pellets were then resuspended
in lysis buffer and 10 ml sucrose buffer, 200 uL of 0.2 M
phenylmethylsolfonyl fluoride (PMSF) , 200 uL protease
inhibitor (PI) was added to each pellet. The cells were rup-
tured through double passage through high-pressure cell
disrupter (Constant Systems Ltd) at 2.30 bar and flushed
with supplemented solubilization buffer (SOB). The solu-
tion was centrifuged for 15 min at 1000 g at 4C in Sigma
6K15 centrifuge (SciQuip Ltd) and subsequently the su-
pernatant was ultracentrifuged in OptimaTM L-80 XP Ul-
tracentrifuge (Beckman Coulter, Fullerton) for 2 hours at
125171 g at 4C. Hereafter, the pellet was resuspended in
supplemented Solubilization buffer. Membrane fractions
were then stored at -80C.
n-dodecyl-β -D-maltosepyranoside (DDM) from Ana-
trace was then added to a final concentration of 1 percent
in order to solubilize LeuT, and then incubated for 1 hour
at 4C under slow rotation. LeuT was bound to ProBond
Ni-IDA resin (Life Technologies), afterwards it was incu-
bated in No Sodium Wash Buffer (NSWB). The membrane
fraction was pelletized by centrifugation at 38.000g for 30
min at 4C by Sorvall LYNX 6000 Superspeed centrifuge
(Thermo Fisher Scientic Inc.). Fluorescein-5-maleimide
(FL) was added dropwise to a final concentration of 200
uM for fluorescent conjugation.The protein-bound resin
was then incubated for 16 hours under slow rotation at 4C,
away from light.
Protein bound resin was centrifuged by Sorvall LYNX
6000 Superspeed centrifuge (Thermo Fisher Scientic Inc.)
at 1.000 rpm for 3 min at 4C with NSWB and the pellets
were then washed with NSWB containing imidazole in or-
der to remove unconjugated fluorescien. Protein elution
was done with 300 mM imidazole. SDS PAGE analysis
was run in order to quantify protein amount in obtained
fractions. Furthermore, protein content was determined at
absorbance at 280 nm with NanoDrop 2000 UV-Vis Spec-
trophotometer (Thermo Fisher Scientic Inc.), correcting
for the protein being fluorescently labeled. Aliquotes of
100 uL were then made and stored at -80C.
3.2 Calculation of protein concentration and degree
of labeling
The total protein concentration of the collected fractions
was determined using Lambert-Beers law: C = A
ε∗l , where
A is the absorbance, ε is the molar absorptions coeffi-
cient and l is the length of the light path. Using ε for
LeuT 113300 Lmol∗cm and ε for fluorescien 80000
L
mol∗cm .
Protein concentration for LeuTK398C was determined to
6.8 uM (1st purification) and 9.9 uM (2nd purification).
For LeuTtmFRET the protein concentration was determined
to 3.1 uM (1st purification) and 1.5 uM (2nd purifica-
tion). For fluorescein the concentration was determined
to 4.4 uM (1st) and 5.3 uM (2nd) for the LeuTK398C mu-
tant. For LeuTtmFRET the concentration was determined
to 2.3 uM (1st) and 1.6 uM (2nd), for fluorescien. The
absorbance was determined by absorption at 480 nm for
fluorescien. From these protein concentrations the degree
of labeling was calculated as [LeuTK398CFL]/[LeuTK398C]
and [LeuTtmFRETFL]/[LeuTtmFRET]
3.3 tmFRET
Samples were prepared for tmFRET by the addition of
0.0005 mg/mL protein to the fluorescence buffer (20 mM
MOPS-KOH buffer pH 7.0 , 200 mM ChCl, 100 uM TCEP
and 0.05 % DDM).
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For the saturation curves, ZnCl2 was added to each sam-
ple at 100uM, 1 mM and 5 mM, respectively. The sample
was mixed well and 330 uL was transferred to each eppen-
dorf tube. Samples were then incubated for one hour at
room temperature, shielded from light. After incubation,
3.3 uL from the following dilution series was was added
to each tube: 1*10-5, 3.16*10-5, 1*10-4 M, 3.16*10-4 M,
1*10-3 M, 3.16*10-3 M, 1*10-2 M, 3.16*10-2 M, 1*10-1 M,
3.16*10-1 M, 1 M. The samples were immediately mea-
sured on the FluoroMax 4 spectrofluorometer (Horiba Sci-
entic Ltd.).
For the Zn2+ titration curves a similar approach was
used. Zn2+ was added to the sample in increasing con-
centrations, 0 M, 0.01 mM, 0.05 mM, 0.1 mM, 0.5 mM,
1 mM, 2 mM and 5 mM, respectively. The sample was
mixed well and 330 uL of the mixture was transfered to
each eppendorf tube. The samples were then incubated at
room temperature, shielded from light for one hour. For
the experiment shown on Figure 10c, 10 mM Ni2+ was
then added to each sample. All samples were then imme-
diately measured on the FluoroMax 4 spectrofluorometer
(Horiba Scientic Ltd.).
Settings for the FluoroMax 4 spectoflurometer: Excita-
tion slit width: 3.5, emission slit width: 3.5, wavelength
excitation: 496 nm, wavelength emission 519 nm. All
measurements were conducted in triplicates.
4 Conclusions
In this study, tmFRET was used for investigating the com-
petitive binding of Zn2+ and Ni2+ at the di-histidine site of
LeuT mutant A313H-A317H-K398C (LeuTtmFRET). Suit-
able buffers were investigated, and it was found that Tris
based buffers were unsuitable, while MOPS based buffers
showed great promise. It was furthermore found that the
pH of the buffer needed to be below 7.5 in order for the
setup to function. It was found that Zn2+ was capable of
inhibiting Ni2+ binding, indicating that a Zn2+ saturated
LeuTtmFRET could be used to remove the signal from un-
bound Ni2+. However, indications that Zn2+ in concentra-
tions above 1 mM increased the fluorescence intensity was
also found. The described technique, however, can still be
utilized at Zn2+ concentrations below 1 mM. Doing so lim-
its the concentration of Ni2+ as well, but it does allow for
investigation of the conformational changes of the protein.
The increase in fluorescence intensity could, however, also
be due to inner filter effect. This finding will allow tm-
FRET measurements to be more consistent as they can be
performed on the same LeuT mutant LeuTtmFRET, as well
as optimize the purification process as the LeuTK398C mu-
tant would be rendered obsolete.
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